XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)
6 Months Ended 12 Months Ended
Feb. 15, 2022
USD ($)
Jan. 27, 2022
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Segment
shares
Dec. 31, 2021
USD ($)
shares
Dec. 30, 2021
shares
Product Information [Line Items]            
Proceeds from issuance of common stock $ 22,000,000          
Reverse stock split description   Effective January 27, 2022, the Company issued 6,798 shares of common stock to round up partial shares resulting from the reverse share split described above   On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022.    
Common stock shares outstanding | shares       7,953,974 1,600,835 240,125,224
Federal insured amount       $ 250,000    
Cash balance, amount       18,637,000    
Cash equivalent balance, amount       18,387,000    
Allowance for doubtful accounts       127,233 $ 181,942  
Goodwill and intangible asset impairment     $ 631,064 631,064  
Contract with customer liability current       4,338,570 2,839,838  
Revenue recognized       $ 2,318,935 $ 3,358,578  
Revenue recognized, percentage       82.00% 90.00%  
Revenue remaining performance obligation       $ 5,577,000    
Product warranty description       The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue    
Product warranty accrual classified current       $ 180,457 $ 186,605  
Product development costs       319,987 469,703  
Share based compensation cost       314,081 $ 324,405  
Share based compensation, incentive compensation awards       $ 89,970    
Number of operating segments | Segment       1    
Warrant [Member]            
Product Information [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount | shares       7,876,334 115,684  
Restricted Stock Units (RSUs) [Member]            
Product Information [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount | shares       7,876,334 115,684  
Share-Based Payment Arrangement, Option [Member]            
Product Information [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount | shares       7,876,334 115,684  
Series B Preferred Stock [Member]            
Product Information [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount | shares       7,876,334 115,684  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage       27.00% 24.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage       26.00% 10.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]            
Product Information [Line Items]            
Concentration risk percentage       11.00% 10.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage       57.00% 68.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage       43.00% 23.00%  
Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier One [Member]            
Product Information [Line Items]            
Concentration risk percentage       30.00% 29.00%  
Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Two [Member]            
Product Information [Line Items]            
Concentration risk percentage       17.00% 11.00%  
Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Three [Member]            
Product Information [Line Items]            
Concentration risk percentage       16.00% 10.00%  
Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Four [Member]            
Product Information [Line Items]            
Concentration risk percentage       11.00%    
One Customer [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation       $ 35,000    
Board Of Directors [Member]            
Product Information [Line Items]            
Share based compensation cost         $ 83,625  
Share based compensation, incentive compensation awards         78,938  
Inventory Valuation and Obsolescence [Member]            
Product Information [Line Items]            
Inventory adjustments       $ 70,907 $ 91,379